The global difficult-to-express protein market is on track for remarkable expansion, with a projected compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, according to a recent report by ...
Sutro Biopharma (NASDAQ:STRO – Get Free Report) is expected to issue its quarterly earnings data before the market opens on ...
Researchers have succeeded in producing nanotubes that fold into cytoskeleton-like structures, using a new RNA origami ...
Label, a certification dedicated to precision fermentation and related animal-free production technologies. The certification ...
Analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Sutro Biopharma in a research note issued ...
Sutro Biopharma, Inc.’s STRO share price has dipped by 35.19%, which has investors questioning if this is right time to buy.
In a groundbreaking study on the synthesis of cellulose – a major constituent of all plant cell walls – a team of Rutgers University-New Brunswick ...
The use of AA tracers has allowed us to uncover complex interactions between muscle protein synthesis (MPS) and muscle protein breakdown ... enters the intracellular AA pool of a muscle cell, it will ...
From Armada to Radio Flyer, these 10 smaller firms are among Fast Company's Most Innovative Companies for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback